BioNeutral Group, Inc Research and Development Expense
BioNeutral Group, Inc reported Research and Development Expense of $213.42 thousand for the 12-month period ending 2013-10-31, per its 10-K filed 2014-02-13.
Discontinued › Expense Statement › Operating Expenses
us-gaap:ResearchAndDevelopmentExpense · last filed 2014-02-13
- BioNeutral Group, Inc research and development expense for fiscal 2013 was $213.42K, a 9.96% decline from fiscal 2012.
- BioNeutral Group, Inc research and development expense for fiscal 2012 was $237.03K, a 62.42% decline from fiscal 2011.
- BioNeutral Group, Inc research and development expense for fiscal 2011 was $630.77K, a 138.20% increase from fiscal 2010.
- BioNeutral Group, Inc research and development expense for fiscal 2010 was $264.81K.
| Period end | Research and Development Expense 12 month |
|---|---|
| 2013-10-31 | $213.42K 10-K · filed 2014-02-13 |
| 2012-10-31 | $237.03K 10-K · filed 2014-02-13 |
| 2011-10-31 | $630.77K 10-K · filed 2013-01-29 |
| 2010-10-31 | $264.81K 10-K · filed 2012-02-10 |